Keywords: Branched Peptides, Doxorubicin, Liposome, Tumor-Targeting, Anthracycline, Linear Neurotensin Peptide Nt, Nanoparticle, Tetrabranched Neurotensin Peptide Nt4, Unclassified Drug, Cell Fusion, Cell Membrane, Controlled Study, Cytotoxicity, Drug Delivery System, Drug Protein Binding, Human, Human Cell, Internalization, Priority Journal, Target Cell, Tumor Cell, Antibiotics, Antineoplastic, Cell Line,
Affiliations: *** IBB - CNR ***
Department of Medical Biotechnology, University of Siena, Via Fiorentina 1, Siena, 53100, Italy
Department of Pharmacy, Centro Interuniversitario di Ricerca sui Peptidi Bioattivi, University of Naples 'Federico II', Istituto di Biostrutture e Bioimmagin, CNR, Via Mezzocannone 16, Naples, 80134, Italy
Istituto Toscano Tumori, Siena, Italy
References: Ohanian, M., Cortes, J., Kantarjian, H., Jabbour, E., Tyrosine kinase inhibitors in acute and chronic leukemias (2012) Expert Opin. Pharmacother., 13 (7), pp. 927-93
Markman, B., Capdevila, J., Elez, E., Tabernero, J., (2009), 1 (6), pp. 965-968. , Immunotherapy New trends in epidermal growth factor receptor-directed monoclonal antibodies
(): -Blanc, V., Bousseau, A., Caron, A., Carrez, C., Lutz, R.J., Lambert, J.M., SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies (2011) Clin. Cancer Res., 17 (20), pp. 6448-6458
Steiner, M., Neri, D., Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends (2011) Clin. Cancer Res., 17, pp. 6406-6416
Ronca, R., Sozzani, S., Presta, M., Alessi, P., Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case (2009) Immunobiology, 214 (9-10), pp. 800-810
Gregoriadis, G., Ryman, B.E., Lysosomal localization of β-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders (1972) Biochem. J., 129, pp. 123-133
Banciu, M., Schiffelers, R.M., Storm, G., Investigation into the role of tumor-associated macrophages in the antitumor activity of doxil (2008) Pharm. Res., 25, pp. 1948-1955
Marcucci, F., Lefoulon, F., Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress (2004) Drug Discov. Today, 9, pp. 219-228
Torchilin, V.P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Delivery, 5, pp. 1003-1025
Sofou, S., Sgouros, G., Antibody-targeted liposomes in cancer therapy and imaging (2008) Expert Opin. Drug Delivery, 5, pp. 189-204
Wu, H.-C., Chang, D.-K., Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy (2010) J. Oncol., , article ID: 723798
DOI:10.1155/2010/723798
Falciani, C., Accardo, A., Brunetti, J., Tesauro, D., Lelli, B., Pini, A., Bracci, L., Morelli, G., Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides (2011) ChemMedChem, 6 (4), pp. 678-685
Bracci, L., Falciani, C., Lelli, B., Lozzi, L., Runci, Y., Pini, A., De Montis, M.G., Neri, P., Synthetic peptides in the form of dendrimers become resistant to protease activity (2003) J. Biol. Chem., 278 (47), pp. 46590-46595
Falciani, C., Lozzi, L., Pini, A., Corti, F., Fabbrini, M., Bernini, A., Lelli, B., Bracci, L., Molecular basis of branched peptides resistance to enzyme proteolysis (2007) Chem. Biol. Drug Des., 69 (3), pp. 216-221
Falciani, C., Brunetti, J., Pagliuca, C., Menichetti, S., Vitellozzi, L., Lelli, B., Pini, A., Bracci, L., Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents (2010) ChemMedChem, 5 (4), pp. 567-574
Falciani, C., Pini, A., Bracci, L., Oligo-branched peptides for tumor targeting: from magic bullets to magic forks (2009) Expert Opin. Biol. Ther., 9 (2), pp. 171-178
Falciani, C., Fabbrini, M., Pini, A., Lozzi, L., Lelli, B., Pileri, S., Brunetti, J., Bracci, L., Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting (2007) Mol. Cancer Ther., 6 (9), pp. 2441-2448
Minervini, A., Siena, G., Falciani, C., Carini, M., Bracci, L., Branched peptides as novel tumor-targeting agents for bladder cancer (2012) Expert Rev. Anticancer Ther., 12 (6), pp. 699-701
Chan, W.C., White, P.D., (2000) Fmoc Solid Phase Peptide Synthesis, , Oxford University Press: New York
Schmitt, L., Dietrich, C., Synthesis and characterization of chelator lipids for reversible immobilization of engineered proteins at self assembled lipid interfaces (1994) J. Am. Chem. Soc., 116, pp. 8485-8491
(): -Blanc, V., Bousseau, A., Caron, A., Carrez, C., Lutz, R. J., Lambert, J. M., SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies (2011) Clin. Cancer Res., 17 (20), pp. 6448-6458
Torchilin, V. P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Delivery, 5, pp. 1003-1025
Wu, H. -C., Chang, D. -K., Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy (2010) J. Oncol., , article ID: 723798
DOI: 10. 1155/2010/723798
Chan, W. C., White, P. D., (2000) Fmoc Solid Phase Peptide Synthesis, , Oxford University Press: New York